6-Fluoro-4-methylpyridine-3-carboxylic acid → HCID 58484588, Verbindung
Reaktionsgleichung
[F:1][C:2]1[CH:10]=[C:9]([CH3:11])[C:5]([C:6]([OH:8])=O)=[CH:4][N:3]=1.[CH:12]1([C:15]2[CH:20]=[C:19]([CH:21]3[CH2:23][CH2:22]3)[CH:18]=[CH:17][C:16]=2[N:24]2[CH2:29][CH2:28][NH:27][CH2:26][CH2:25]2)[CH2:14][CH2:13]1>>[CH:12]1([C:15]2[CH:20]=[C:19]([CH:21]3[CH2:23][CH2:22]3)[CH:18]=[CH:17][C:16]=2[N:24]2[CH2:25][CH2:26][N:27]([C:6]([C:5]3[CH:4]=[N:3][C:2]([F:1])=[CH:10][C:9]=3[CH3:11])=[O:8])[CH2:28][CH2:29]2)[CH2:13][CH2:14]1Komponenten
3
Versuchsvorschrift
Using 6-fluoro-4-methylnicotinic acid (386 mg) and 1-(2,4-dicyclopropylphenyl)piperazine (650 mg) described in Preparation Example 101 and by the reaction and treatment in the same manner as in Preparation Example 118, the title compound (980 mg) was obtained.
Aufarbeitung
- customdescribed in Preparation Example 101 and by the reaction and treatment in the same manner as in Preparation Example 118
Quellen und Nachweise
- ORD-Eintrag
- ord-2857f953ab9e4c88a45d7b07ef7bb419
- Quelldatensatz
- uspto-grants-2014_08
- Patentnummer
- US08816079B2
Notizen zur Reaktion
Wird geladen…